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Introduction

Figures

Discussion

Malaria is a mosquito borne disease caused by the parasite, plasmodium, that
infects the anopheles mosquito which feeds on humans. Plasmodium
falciparum is a wide spread parasite across the worlds transmitted in 95
countries where 2.8 billion people are at risk for infection. Clinical
manifestations include high fevers, shaking chills and flu like illnesses.
Although malaria can be fatal, morbidity and mortality from malaria can
usually be prevented. Roughly 1,700 cases of malaria are diagnosed in the
united states each year. The vast majority of cases in the US are in travelers or
immigrants returning from countries where malaria transmission occur such as
sub-Saharan Africa and Southeast Asia (1,2,3)

i. In areas where malaria is endemic, groups at high risk for severe malaria
include pregnant female, neonates and the immunocompromised. Adults wit
repeated exposure tend to develop partial immunity. Travelers to area where
malaria is endemic generally don’t have previous exposure to malaria and risk
developing severe malarial sepsis.(1)
ii. Malaria should be on a differential in patients with any febrile illness after
exposure in an area that is endemic to the Plasmodium species, The initial
symptoms and clinical presentation, similar to that of our patient are usually
nonspecific such as body aches, chills, fever, fatigue and other flu like
symptoms. (1,3)
iii. Laboratory techniques consist of

Case Report

i. Capillary blood should be obtained by fingerstick, or venous
should be obtained by venipuncture.

A 51 year old Caucasian male patient with a past medical history of
environmental hemochromatosis, hypothyroidism and gun shot wounds
was admitted to our hospital for fever/chills x 4 days with a progressive
course since onset. In the first 2 days of symptoms, patient developed
nausea, vomiting, non bloody diarrhea, anorexia, myalgias, arthralgias,
sore throat, chest pain, headache, dark urine and 4/10 LUQ
exacerbated by inspiration. He has been taking Tylenol with no relief of
his symptoms. He was seen at an urgent care the morning of his
admissions where CXR, rapid strep and flu were negative, and was
advised to come to the ED. He reports recent travel from Cameroon for
his work as a counter terrorism advisor for 25 days. He ate local foods,
He took doxycycline for 6 days for malaria prophylaxis but believes he
may have started the regimen a few days late. He was already up to
date on yellow fever per previous records. In addition, he did not
receive his annual flu vaccine.
Microscopic slides of thick and thin Giemsa stained blood smear
demonstrated the presence of ring formed trophozoites of Plasmodium
species with 1% parasitemia. On admission, rapid malaria antigen was
consistent with plasmodium falciparum. Infectious disease was
consulted and the patient was started on oral Atovaquone/proguanil for
7 days. Daily peripheral smears were ordered and the last screen on
12/09 was negative. During the course of the patients hospitalization,
his thrombocytopenia, liver function and renal function continued to
improve. There was no evidence of active bleed. His Computerized
tomography scan was significant for for splenomegaly, consistent with
malaria. Prior to discharge, the patient was medically stable. The
patients Dengue IgM serology was negative but IgG was positive per
previous records. Infectious disease will subsequently follow up for
outpatient care.
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ii. Blood smears, at least two thick and two thin, should be prepared
as soon as possible after collection. Delay in preparation of the
smears can result in changes in parasite morphology and staining
characteristics.
iii. Schuffner dots can be demonstrated in giemsa stain, which is
preferred to wright or wright giemsa stain (3)
iv. The approach to selecting an antimalarial drug is determined
whether the parasite was acquired in a region with chloroquine
sensitivity or resistance determined by local government
treatment guidelines/and or drug availability in a region. In
general, treatment of uncomplicated malaria outside an endemic
area such as the united states consists of a combination of two
agents. In this case, Atovaquone-proguanil was prescribed. (4)
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Trophozoites seen above are old
ring stage parasites are and are
rarely seen on peripheral blood
smears of Plasmodium falciparum.

The smear above contains a single
schizont which usually ruptures
and releases the infective form of
plasmodium, merozoites.
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